Literature DB >> 25050900

Exome sequencing identifies a novel homozygous mutation in the phosphate transporter SLC34A1 in hypophosphatemia and nephrocalcinosis.

Abbhirami Rajagopal1, Débora Braslavsky, James T Lu, Soledad Kleppe, Florencia Clément, Hamilton Cassinelli, David S Liu, Jose Miguel Liern, Graciela Vallejo, Ignacio Bergadá, Richard A Gibbs, Phillipe M Campeau, Brendan H Lee.   

Abstract

CONTEXT: Two Argentinean siblings (a boy and a girl) from a nonconsanguineous family presented with hypercalcemia, hypercalciuria, hypophosphatemia, low parathyroid hormone (PTH), and nephrocalcinosis.
OBJECTIVE: The goal of this study was to identify genetic causes of the clinical findings in the two siblings.
DESIGN: Whole exome sequencing was performed to identify disease-causing mutations in the youngest sibling, and a candidate variant was screened in other family members by Sanger sequencing. In vitro experiments were conducted to determine the effects of the mutation that was identified. PATIENTS AND OTHER PARTICIPANTS: Affected siblings (2 y.o. female and 10 y.o male) and their parents were included in the study. Informed consent was obtained for genetic studies.
RESULTS: A novel homozygous mutation in the gene encoding the renal sodium-dependent phosphate transporter SLC34A1 was identified in both siblings (c.1484G>A, p.Arg495His). In vitro studies showed that the p.Arg495His mutation resulted in decreased phosphate uptake when compared to wild-type SLC34A1.
CONCLUSIONS: The homozygous G>A transition that results in the substitution of histidine for arginine at position 495 of the renal sodium-dependent phosphate transporter, SLC34A1, is involved in disease pathogenesis in these patients. Our report of the second family with two mutated SLC34A1 alleles expands the known phenotype of this rare condition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25050900      PMCID: PMC4223446          DOI: 10.1210/jc.2014-1517

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Effect of parathyrin on the transport properties of isolated renal brush-border vesicles.

Authors:  C Evers; H Murer; R Kinne
Journal:  Biochem J       Date:  1978-04-15       Impact factor: 3.857

2.  Elevated serum 1,25-dihydroxyvitamin D concentrations in siblings with primary Fanconi's syndrome.

Authors:  M Tieder; R Arie; D Modai; R Samuel; J Weissgarten; U A Liberman
Journal:  N Engl J Med       Date:  1988-09-29       Impact factor: 91.245

3.  Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2.

Authors:  Hien Chau; Sherif El-Maadawy; Marc D McKee; Harriet S Tenenhouse
Journal:  J Bone Miner Res       Date:  2003-04       Impact factor: 6.741

4.  A dibasic motif involved in parathyroid hormone-induced down-regulation of the type IIa NaPi cotransporter.

Authors:  Z Karim-Jimenez; N Hernando; J Biber; H Murer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

5.  Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis.

Authors:  Philippe M Campeau; James T Lu; Gautam Sule; Ming-Ming Jiang; Yangjin Bae; Simran Madan; Wolfgang Högler; Nicholas J Shaw; Steven Mumm; Richard A Gibbs; Michael P Whyte; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2012-08-08       Impact factor: 6.150

Review 6.  Posttranscriptional regulation of the proximal tubule NaPi-II transporter in response to PTH and dietary P(i).

Authors:  H Murer; I Forster; N Hernando; G Lambert; M Traebert; J Biber
Journal:  Am J Physiol       Date:  1999-11

7.  Renal expression of the sodium/phosphate cotransporter gene, Npt2, is not required for regulation of renal 1 alpha-hydroxylase by phosphate.

Authors:  H S Tenenhouse; J Martel; C Gauthier; M Y Zhang; A A Portale
Journal:  Endocrinology       Date:  2001-03       Impact factor: 4.736

8.  Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa.

Authors:  Leila V Virkki; Ian C Forster; Nati Hernando; Jürg Biber; Heini Murer
Journal:  J Bone Miner Res       Date:  2003-12       Impact factor: 6.741

9.  Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter.

Authors:  Dominique Prié; Virginie Huart; Naziha Bakouh; Gabrielle Planelles; Olivier Dellis; Bénédicte Gérard; Philippe Hulin; François Benqué-Blanchet; Caroline Silve; Bernard Grandchamp; Gérard Friedlander
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

Review 10.  The sodium phosphate cotransporter family SLC34.

Authors:  Heini Murer; Ian Forster; Jürg Biber
Journal:  Pflugers Arch       Date:  2003-05-16       Impact factor: 3.657

View more
  15 in total

1.  Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia.

Authors:  Karl P Schlingmann; Justyna Ruminska; Martin Kaufmann; Ismail Dursun; Monica Patti; Birgitta Kranz; Ewa Pronicka; Elzbieta Ciara; Teoman Akcay; Derya Bulus; Elisabeth A M Cornelissen; Aneta Gawlik; Przemysław Sikora; Ludwig Patzer; Matthias Galiano; Veselin Boyadzhiev; Miroslav Dumic; Asaf Vivante; Robert Kleta; Benjamin Dekel; Elena Levtchenko; René J Bindels; Stephan Rust; Ian C Forster; Nati Hernando; Glenville Jones; Carsten A Wagner; Martin Konrad
Journal:  J Am Soc Nephrol       Date:  2015-06-05       Impact factor: 10.121

2.  Gene panel sequencing identifies a likely monogenic cause in 7% of 235 Pakistani families with nephrolithiasis.

Authors:  Ali Amar; Amar J Majmundar; Ihsan Ullah; Ayesha Afzal; Daniela A Braun; Shirlee Shril; Ankana Daga; Tilman Jobst-Schwan; Mumtaz Ahmad; John A Sayer; Heon Yung Gee; Jan Halbritter; Thomas Knöpfel; Nati Hernando; Andreas Werner; Carsten Wagner; Shagufta Khaliq; Friedhelm Hildebrandt
Journal:  Hum Genet       Date:  2019-02-18       Impact factor: 4.132

Review 3.  Renal phosphate handling and inherited disorders of phosphate reabsorption: an update.

Authors:  Carsten A Wagner; Isabel Rubio-Aliaga; Nati Hernando
Journal:  Pediatr Nephrol       Date:  2017-12-23       Impact factor: 3.714

4.  Significant association between RGS14 rs12654812 and nephrolithiasis risk among Guangxi population in China.

Authors:  Jun Long; Yang Chen; Haisong Lin; Ming Liao; Tianyu Li; Lei Tong; Suchun Wei; Xiaoying Xian; Jia Zhu; Jianxin Chen; Jiarong Tian; Qiuyan Wang; Zengnan Mo
Journal:  J Clin Lab Anal       Date:  2018-03-26       Impact factor: 2.352

5.  Analysis of opossum kidney NaPi-IIc sodium-dependent phosphate transporter to understand Pi handling in human kidney.

Authors:  Toru Fujii; Yuji Shiozaki; Hiroko Segawa; Shiori Nishiguchi; Ai Hanazaki; Miwa Noguchi; Ruri Kirino; Sumire Sasaki; Kazuya Tanifuji; Megumi Koike; Mizuki Yokoyama; Yuki Arima; Ichiro Kaneko; Sawako Tatsumi; Mikiko Ito; Ken-Ichi Miyamoto
Journal:  Clin Exp Nephrol       Date:  2018-10-13       Impact factor: 2.801

6.  Pharmacological Npt2a Inhibition Causes Phosphaturia and Reduces Plasma Phosphate in Mice with Normal and Reduced Kidney Function.

Authors:  Linto Thomas; Jianxiang Xue; Sathish Kumar Murali; Robert A Fenton; Jessica A Dominguez Rieg; Timo Rieg
Journal:  J Am Soc Nephrol       Date:  2019-08-13       Impact factor: 10.121

7.  Loss of function of NaPiIIa causes nephrocalcinosis and possibly kidney insufficiency.

Authors:  Dganit Dinour; Miriam Davidovits; Liat Ganon; Justyna Ruminska; Ian C Forster; Nati Hernando; Eran Eyal; Eli J Holtzman; Carsten A Wagner
Journal:  Pediatr Nephrol       Date:  2016-07-04       Impact factor: 3.714

8.  Expression of NaPi-IIb in rodent and human kidney and upregulation in a model of chronic kidney disease.

Authors:  Sarah E Motta; Pedro Henrique Imenez Silva; Arezoo Daryadel; Betül Haykir; Eva Maria Pastor-Arroyo; Carla Bettoni; Nati Hernando; Carsten A Wagner
Journal:  Pflugers Arch       Date:  2020-03-26       Impact factor: 3.657

9.  The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease.

Authors:  Walter G Wasser; Amnon Gil; Karl L Skorecki
Journal:  Rambam Maimonides Med J       Date:  2015-07-30

10.  The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction.

Authors:  Thomas Knöpfel; Eva M Pastor-Arroyo; Udo Schnitzbauer; Denise V Kratschmar; Alex Odermatt; Giovanni Pellegrini; Nati Hernando; Carsten A Wagner
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.